Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
SEC
Biotech
Cassava scores a win as FDA declines to halt Alzheimer's trials
Cassava Sciences has chalked up one win in an ongoing battle over the integrity of its clinical trials for Alzheimer’s disease.
Annalee Armstrong
Feb 11, 2022 9:34am
CytoDyn ousts CEO Pourhassan after a wild year
Jan 26, 2022 10:30am
After FDA U-turn, Amylyx heads for IPO to support ALS drug
Dec 17, 2021 10:45am
Ex-Immunomedics CFO Malik charged with insider trading
Dec 2, 2021 3:30pm
Cassava starts another Alzheimer's med trial amid fed inquiries
Nov 18, 2021 11:30am
Pfizer and Trillium: How a $25M investment led to a $2.3B buyout
Sep 14, 2021 8:05am
